Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment
In Brief: ASCO Selects Four New Board Members; Mount Sinai’s Shank To Move To California
In Congress: Human Genome Project Ahead Of Schedule, Collins Assert
Health Disparities Between Minorities Too Large, Shalala Says
Funding Opportunities: NIH Creates Awards For Clinical Research
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









